Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06368323 · ClinicalTrials.gov registry record · NA
Effect of Community Choir Singing in People With Chronic Post-stroke Aphasia
A NA study of Aphasia, sponsored by University of Ottawa.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 4
- Study locations
NCT06368323: Recruiting NA study of Aphasia, sponsored by University of Ottawa.
NCT06368323 is a NA study of Aphasia that is actively recruiting participants, run by University of Ottawa. The registered enrollment target is 50 participants, below the 82-participant average among 42 other Aphasia trials with a reported enrollment target (39% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06368323, a NA study of Aphasia, is actively recruiting participants, sponsored by University of Ottawa.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 4
- Study locations
Study Summary
The goal of this randomized controled trial is to test the effects of assigning people with chronic post-stroke aphasia to 12 weekly choir sessions, compared to usual care. The main question it aims to answer is: Does the assignment to a choir singing program causes a beneficial effect on functional communication and language recovery as well as psychosocial outcomes compared to usual care in the rehabilitation of people with chronic post-stroke aphasia? Participants will have: 12 in-person choir-singing sessions (1 session/week, 1,5 h/session, total 18h) conducted by a choir master, and home singing training (3 x 30-minutes-sessions/week, total 18h)
Primary Outcome
The ability to communicate one's feelings and basic needs effectively / is computed by averaging the percentage scores (score/total×100) of the Communicative Activity Log (CAL) and the communication subscale of the Stroke Impact Scale 3.0 (SIS). Minimum value=0; Maximum value=100; Higher scores mean a better outcome.
Conditions Studied
Interventions
- OTHER Usual care
- BEHAVIORAL Choir singing
Study Locations (4)
Ontario
- University of Ottawa - Ottawa
- Toronto Metropolitan University - Toronto
Florida
- University of South Florida - Tampa
Quebec
- Université de Montréal - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What NCT06368323 shows while recruiting
NCT06368323 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 82-participant average among 42 other Aphasia trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Aphasia appearing as the primary indexed condition, and to 2 interventions - of which Usual care is the first listed.
NCT06368323 reports a single indexed study location in Ontario, Florida, Quebec.
Frequently Asked Questions
What is clinical trial NCT06368323 about?
NCT06368323 is a clinical study titled "Effect of Community Choir Singing in People With Chronic Post-stroke Aphasia". The goal of this randomized controled trial is to test the effects of assigning people with chronic post-stroke aphasia to 12 weekly choir sessions, compared to usual care. The main question it aims to answer is: Does the assignment to a choir singing program causes a beneficial effect on function...
What is the current status of trial NCT06368323?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-04-22. Estimated completion is 2027-09-30.
What conditions does trial NCT06368323 study?
This clinical trial studies the following conditions: Aphasia.
What interventions are being tested in trial NCT06368323?
The interventions under investigation include: Usual care (OTHER), Choir singing (BEHAVIORAL).
Who is sponsoring clinical trial NCT06368323?
This trial is sponsored by University of Ottawa, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06368323 being conducted?
This trial has 4 study locations across Florida, Ontario, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aphasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06368323's enrollment target sits among peer trials
50 24th of 42 higher than 15 of 42 other Aphasia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aphasia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Transcranial Alternating Current Stimulation (tACS) in Aphasia
RECRUITING · NA
-
tACS to Enhance Language Abilities
RECRUITING · NA
-
Treatment Outcomes With tDCS in Post-Stroke Aphasia
RECRUITING · NA
-
Telerehabilitation for Aphasia (TERRA)
RECRUITING · NA
-
Combined Exercise and Targeted Therapy for Post-Stroke Reading Deficits
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI